Last reviewed · How we verify
NCT02589288
Adductor Canal Block: Continuous Infusion Versus Automatic Intermittent Bolus For Postoperative Analgesia After Day-Case Anterior Cruciate Ligament Reconstruction
NA trial testing Continuous Infusion of ropivacaine 0.2% in Injury of Anterior Cruciate Ligament in 80 participants. Completed in 1 March 2017.
1 December 2016
Quick facts
| Lead sponsor | ASST Gaetano Pini-CTO |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 1 November 2015 |
| Primary completion | 1 December 2016 |
| Estimated completion | 1 March 2017 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Continuous Infusion of ropivacaine 0.2% — full drug profile →
- Automatic Intermittent Bolus of ropivacaine 0.2%
Conditions studied
- Injury of Anterior Cruciate Ligament — all drugs for Injury of Anterior Cruciate Ligament →
Sponsor
ASST Gaetano Pini-CTO — full company profile →
Who can join
18 and older, any sex, with Injury of Anterior Cruciate Ligament. Patients with the condition only — healthy volunteers not accepted.
What's being measured
Primary outcomes are the specific endpoints the trial is designed to prove or disprove.
-
NRS Score
Time frame: 72h postoperative
Evaluation of numeric rating score (NRS) in patient with automatic intermittent bolus of Ropivacaine 0,2% instead of classic continuous perfusion
Sponsor's own description
The aim of this prospective, randomized , blinded study is to compare two different infusion techniques (continuous VS intermittent automatic bolus) to assess the effects of postoperative analgesia after Day-Case anterior cruciate ligament (ACL) reconstruction.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02589288
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other ASST Gaetano Pini-CTO trials
Trials by the same sponsor.
- NCT07239817 — PENG Block + LIA For Endoprosthesis Surgery With Anterior Approach · NA · recruiting
- NCT03211260 — Effects of Proprioceptive Focal Stimulation (EQUISTASI) on Freezing of Gait in Parkinson's Disease · NA · terminated
- NCT03406988 — Autologous Adipose Tissue in the Treatment of Systemic Sclerosis Digital Ulcers · NA · unknown
- NCT03060928 — Evaluation of Tendon-to-Bone Healing Potential in Arthroscopic Rotator Cuff Repair Through Biological Stimulation · NA · unknown
- NCT03092466 — Early Femoral Block in Elderly With Hip Fracture · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02589288 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by ASST Gaetano Pini-CTO
- Last refreshed: 11 August 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02589288.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing